ANGIOSAFE
Angiosafe is a clinical device company. They provide medical devices for preclinical and clinical development. They develop a pipeline of novel devices to simplify and improve complex interventional algorithms.
ANGIOSAFE
Social Links:
Industry:
Health Diagnostics Medical Medical Device
Founded:
2014-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.angiosafe.com
Total Employee:
11+
Status:
Active
Contact:
+1 669 400 8383
Technology used in webpage:
U.S. Server Location
Similar Organizations
AccuQuest Hearing Centers
AccuQuest Hearing Centers is a medical devices company.
CoolSculpting
CoolSculpting is a medical device company.
HydraVascular
HydraVascular is a medical device company.
Intelligent Hearing Systems
Intelligent Hearing Systems is a medical devices company.
Mirai Medical
Mirai Medical is a medical device company.
Eng3
Eng3 is a medical device company.
Supreme Orthopedic Systems
Supreme Orthopedic Systems is a medical device company.
TalkTools
TalkTools is a medical device company.
Tromp Medical
Tromp Medical is a medical imaging sales and service organization.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.angiosafe.com Semrush global rank: 14.7 M Semrush visits lastest month: 37
- Host name: 99.236.12.198.host.secureserver.net
- IP address: 198.12.236.99
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Angiosafe"
AngioSafe
Solving Challenges of Complex Interventions in Coronary and Peripheral Arterial Diseases (CAD and PAD) * Roth, G.A., et al., Global Burden of Cardiovascular Disease and Risk Factors, …See details»
AngioSafe
A growing organization with plans for commercial approvals and launches. Investors: [email protected] Information: [email protected]See details»
Angiosafe - Crunchbase Company Profile & Funding
Organization. Angiosafe . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Angiosafe is a medical device company. San Jose, …See details»
AngioSafe, Inc. - LinkedIn
AngioSafe is a pre-commercial stage company developing a pipeline of devices to address the challenges of complexity, safety and efficacy of cardiovascular interventions in peripheral and coronary ...See details»
Angiosafe Company Profile 2024: Valuation, Funding
Angiosafe General Information Description. Developer of novel devices designed to simplify and improve complex interventional algorithms. The company creates a pipeline of devices for complex interventions in coronary and peripheral …See details»
AngioSafe
AngioSafe Leadership and Strategic Advisors Backed by >200 additional years of engineering, clinical, nonclinical, manufacturing experience. Ram Reddy. AngioSafe co-founder, investor, and Board Chairman Seasoned Silicon Valley …See details»
Angiosafe, Inc. Company Profile | San Jose, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Angiosafe, Inc. of San Jose, CA. Get the latest business insights from Dun & Bradstreet.See details»
Angiosafe - Products, Competitors, Financials, Employees, …
Angiosafe is a pre-commercial stage company involved in the development of devices for cardiovascular interventions. The company's offerings include a series of patented devices …See details»
Angiosafe - Contacts, Employees, Board Members, Advisors
Organization. Angiosafe . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies ... Number of Board Member and Advisor Profiles 1. Contacts 4. …See details»
AngioSafe Peripheral CTO Crossing System in Peripheral ... - ICH GCP
Dec 1, 2020 The purpose of the study is to demonstrate the safety and effectiveness of the AngioSafe Peripheral CTO Crossing System. The system facilitates the crossing of chronic …See details»
Angiosafe - Crunchbase
Angiosafe is a medical device company. Start Free Trial . Chrome ExtensionSee details»
AngioSafe
Subhash Banerjee, M.D., FACC, FSCAI. National Principal Investigator, AngioSafe Peripheral program Professor, UT Southwestern Chief of Cardiology and Director, Cardiac …See details»
Mallik Thatipelli - Founder and Chief Innovation Officer
Angiosafe Inc. · Dr. Thatipelli is a Vascular and Interventional specialist with advanced training at Mayo Clinic and Tufts University. He is serving in clinical practice for over ten years. He ...See details»
AngioSafe, Inc. | CipherBio
Explore AngioSafe, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
AngioSafe, Inc. hiring Clinical Operations Specialist in San Jose ...
AngioSafe complies with all applicable local, state, and national laws governing non-discrimination in employment. Salary Range: $125,000 - $200,000 , varies depending on skill and experience …See details»
AngioSafe
AngioSafe is growing.... Seeking engineers (design, test, manufacturing, quality), technicians and assemblers, and experts in clinical science, regulatory, quality, finance, operations, and …See details»
Angiosafe - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Angiosafe . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. Angiosafe is actively using …See details»
AngioSafe
Develop a pipeline of novel devices to simplify and improve complex interventional algorithms. Enable complex coronary and peripheral vascular interventions by all interventionists in all …See details»
John Annecone - Operations - AngioSafe | LinkedIn
Operations at AngioSafe · Over 20 years’ experience in Manufacturing or Operations capacity in three distinctively different industries improving production lines, increasing quality and adding ...See details»
Glucagon-like Peptide 1 Receptor Agonists, Diabetic Retinopathy …
Oct 7, 2019 AngioSafe 1 is an ongoing 3-year longitudinal study (NCT02671864) to determine the safety of antidiabetic drugs in the retina and angiogenesis. The overall study aims to …See details»